Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions

European Journal of Cancer

Volumn 44, Issue 17, 2008, Pages 2689-2695

  Ramirez N ^a   Bandres E ^a   Navarro, A ^b   Pons, A ^b   Jansa, S ^b   Moreno, I ^c   Martinez Rodenas F ^c   Zarate R ^a   Bitarte, N ^a   Monzo M ^b   Garcia Foncillas J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Hospital Municipal   (Spain)

Author keywords

Colorectal cancer; Epigenetic events; Field cancerisation; Normal colonic tissue

Indexed keywords

B RAF KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; K RAS PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; ONCOPROTEIN; PROTEIN MLH1; PROTEIN P53; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL TYPE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; EARLY CANCER; EPIGENETICS; FEMALE; GENE INACTIVATION; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENES, NEOPLASM; GENES, P53; GENES, RAS; HUMANS; INTESTINAL MUCOSA; LYMPHATIC METASTASIS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 55249093832     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.09.004     Document Type: Article

References (36)

1. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 5 (1990) 759-767
2. Powell S.M., Zilz N., Beazer-Barclay Y., Bryan T.M., Hamilton S.R., Thibodeau S.N., et al. APC mutations occur early during colorectal tumorigenesis. Nature 359 6392 (1992) 235-237
3. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 2 (1996) 159-170
4. Ishiguro A., Takahata T., Saito M., Yoshiya G., Tamura Y., Sasaki M., et al. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer. J Gastroenterol Hepatol 21 8 (2006) 1334-1339
5. Kim H.C., Roh S.A., Ga I.H., Kim J.S., Yu C.S., and Kim J.C. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. J Gastroenterol Hepatol 20 12 (2005) 1920-1926
6. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 6712 (1998) 643-649
7. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 6 (2002) 415-428
8. Toyota M., Ahuja N., Suzuki H., Itoh F., Ohe-Toyota M., Imai K., et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59 21 (1999) 5438-5442
9. Toyota M., Ohe-Toyota M., Ahuja N., and Issa J.P. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci USA 97 2 (2000) 710-715
10. Jones P.A., and Laird P.W. Cancer epigenetics comes of age. Nat Genet 21 2 (1999) 163-167
11. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 60 16 (2000) 4366-4371
12. Raedle J., Trojan J., Brieger A., Weber N., Schafer D., Plotz G., et al. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med 135 8 Pt 1 (2001) 566-576
13. Lee M., Sup Han W., Kyoung Kim O., Hee Sung S., Sun Cho M., Lee S.N., et al. Prognostic value of p16INK4a and p14ARF gene hypermethylation in human colon cancer. Pathol Res Pract 202 6 (2006) 415-424
14. Shen L., Toyota M., Kondo Y., Lin E., Zhang L., Guo Y., et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci USA 104 47 (2007) 18654-18659
15. Kawakami K., Ruszkiewicz A., Bennett G., Moore J., Grieu F., Watanabe G., et al. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Brit J Cancer 94 4 (2006) 593-598
16. Ye C., Shrubsole M.J., Cai Q., Ness R., Grady W.M., Smalley W., et al. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Oncol Rep 16 2 (2006) 429-435
17. Hsieh C.J., Klump B., Holzmann K., Borchard F., Gregor M., and Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 58 17 (1998) 3942-3945
18. Issa J.P., Ahuja N., Toyota M., Bronner M.P., and Brentnall T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61 9 (2001) 3573-3577
19. Shen L., Kondo Y., Rosner G.L., Xiao L., Hernandez N.S., Vilaythong J., et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 97 18 (2005) 1330-1338
20. Slaughter D.P., Southwick H.W., and Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6 5 (1953) 963-968
21. Dong S.M., Lee E.J., Jeon E.S., Park C.K., and Kim K.M. Progressive methylation during the serrated neoplasia pathway of the colorectum. Mod Pathol 18 2 (2005) 170-178
22. Judson H., Stewart A., Leslie A., Pratt N.R., Baty D.U., Steele R.J., et al. Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas. J Pathol 210 3 (2006) 344-350
23. Deng G., Bell I., Crawley S., Gum J., Terdiman J.P., Allen B.A., et al. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer. Clin Cancer Res 10 1 (2004) 191-195
24. Fransen K., Klintenas M., Osterstrom A., Dimberg J., Monstein H.-J., and Soderkvist P. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 25 4 (2004) 527-533
25. Berg K.D., Glaser C.L., Thompson R.E., Hamilton S.R., Griffin C.A., and Eshleman J.R. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagnost 2 1 (2000) 20-28
26. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. New Engl J Med 349 21 (2003) 2042-2054
27. Jackson P.E., Hall C.N., O'Connor P.J., Cooper D.P., Margison G.P., and Povey A.C. Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC → AT transition in the K-ras oncogene. Carcinogenesis 18 7 (1997) 1299-1302
28. Esteller M., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Watkins D.N., et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60 9 (2000) 2368-2371
29. Kuismanen S.A., Holmberg M.T., Salovaara R., Schweizer P., Aaltonen L.A., de La Chapelle A., et al. Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers. Proc Natl Acad Sci USA 96 22 (1999) 12661-12666
30. Van Aken J., Cuvelier C.A., De Wever N., Roels J., Gao Y., and Mareel M.M. Immunohistochemical analysis of E-cadherin expression in human colorectal tumours. Pathol Res Pract 189 9 (1993) 975-978
31. Ogino S., Odze R.D., Kawasaki T., Brahmandam M., Kirkner G.J., Laird P.W., et al. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol 30 9 (2006) 1175-1183
32. Yi J., Wang Z.W., Cang H., Chen Y.Y., Zhao R., Yu B.M., et al. p16 gene methylation in colorectal cancers associated with Duke's staging. World J Gastroenterol 7 5 (2001) 722-725
33. Kim B.N., Yamamoto H., Ikeda K., Damdinsuren B., Sugita Y., Ngan C.Y., et al. Methylation and expression of p16INK4 tumor suppressor gene in primary colorectal cancer tissues. Int J Oncol 26 5 (2005) 1217-1226
34. Zielinski S.L. Press release: change in gene may be underlying molecular defect in some colorectal cancers, study suggests. J Natl Cancer Inst 97 18 (2005) 1315
35. Giovannucci E., and Ogino S. DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 97 18 (2005) 1317-1319
36. Suzuki K., Suzuki I., Leodolter A., Alonso S., Horiuchi S., Yamashita K., et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9 3 (2006) 199-207